Alx oncology announces two evorpacept clinical abstracts accepted for presentation at the aacr annual meeting

- investigator-initiated trial in patients with relapsed or refractory b-cell non-hodgkin lymphoma selected for oral presentation

ALXO Ratings Summary

ALXO Quant Ranking